Suprax may be taken with or without food. A high-fat meal can delay absorption slightly, but the overall effectiveness remains unchanged. If gastrointestinal upset occurs, taking the pill with a small amount of food may improve tolerability.
Mild diarrhoea is a common side effect and often resolves after completing therapy. however, if stools become watery, frequent, or are accompanied by abdominal pain or fever, contact a healthcare professional promptly as this may signal Clostridioides difficile-associated diarrhoea.
Yes. In the UK, the 100 mg tablet is typically round and white, while the 200 mg tablet is oval and yellowish-white. The imprint code on the tablet surface (e.g., “100” or “200” along with the brand logo) helps distinguish the strengths.
Cefixime is classified as Category B in the UK, indicating no evidence of risk in animal studies but limited data in humans. It should only be prescribed during pregnancy when the expected benefit outweighs any potential risk to the fetus.
Suprax is not a prohibited substance under UK anti-doping regulations, and it does not typically cause a positive result on standard workplace drug screens, which target drugs of abuse rather than antibiotics.
The manufacturer guarantees potency only up to the printed expiry date. After this date, the chemical stability may be compromised, and the medication should be discarded rather than used.
Unused Suprax should be returned to a pharmacy’s medication-take-back scheme or placed in a sealed container before disposal in the household waste, according to UK NHS guidance for safe drug disposal.
Antacids containing aluminium or magnesium can reduce cefixime absorption. To avoid this interaction, take Suprax at least two hours before or after an antacid.
For uncomplicated genital gonorrhoea caused by susceptible Neisseria gonorrhoeae, a single oral dose of 400 mg Suprax (two 200 mg tablets) is an approved regimen in the UK, provided local resistance patterns support its use.
No. Suprax targets bacterial infections and has no activity against viruses. Using antibiotics for viral illnesses contributes to antimicrobial resistance and offers no clinical benefit.
Suprax is a prescription-only antibiotic marketed in the United Kingdom under the brand name Suprax. The active ingredient in Suprax is cefixime, a third-generation cephalosporin. Suprax is supplied as an oral pill, available in strengths of 100 mg and 200 mg. It is authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) and is typically prescribed by a qualified NHS prescriber for bacterial infections that are susceptible to cefixime. The product is manufactured by Pfizer Ltd. and is classified as a prescription (Rx) medication in the UK.
Cefixime belongs to the cephalosporin family of antibiotics. Its primary mechanism is the inhibition of bacterial cell-wall synthesis:
Cefixime is absorbed well after oral ingestion, reaching peak plasma concentrations within 2-3 hours. It is primarily excreted unchanged in the urine, which accounts for its effectiveness in urinary-tract infections.
Suprax (cefixime) is approved by the MHRA for the following adult and paediatric indications, provided the infecting organism is proven or highly likely to be susceptible:
These indications reflect the antibiotic’s activity against common respiratory, urinary, and sexually transmitted pathogens. Treatment duration is typically 5-7 days, but the exact length should follow the prescriber’s assessment and local clinical guidelines.
Some clinicians consider cefixime for infections not listed on the product licence, provided there is supporting evidence and the benefits outweigh risks. Notable off-label applications include:
These uses are not approved by the MHRA. Off-label use requires thorough medical supervision and an individualized risk-benefit assessment.
These reactions are generally transient and resolve after therapy is completed.
If any serious symptom develops, the patient should seek immediate medical attention.
This article provides educational information about Suprax and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
